Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-045022
Filing Date
2021-07-02
Accepted
2021-07-02 16:48:41
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4260
  Complete submission text file 0001209191-21-045022.txt   5702
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Reporting) CIK: 0001055919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37744 | Film No.: 211070931

Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Issuer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus